Clinical Investigation of Fasudil for the Prevention of Cerebral Vasospasm in Extracranial Carotid Artery Stenting

[1]  Paul Vespa,et al.  Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2012, Stroke.

[2]  E. Keller,et al.  Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought , 2009, Neurological research.

[3]  C. Schirmer,et al.  Iatrogenic vasospasm in carotid artery stent angioplasty with distal protection devices. , 2008, Neurosurgical focus.

[4]  E. Peterson,et al.  ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Document Committee on Carotid Stenting). , 2007, Journal of the American College of Cardiology.

[5]  E. Peterson,et al.  ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. , 2007, Vascular medicine.

[6]  P. Ganz,et al.  Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease , 2006, Circulation research.

[7]  V. Feigin,et al.  Calcium Antagonists in Aneurysmal Subarachnoid Hemorrhage , 2005, The Cochrane database of systematic reviews.

[8]  Thomas Jahnke,et al.  Vessel wall damage caused by cerebral protection devices: ex vivo evaluation in porcine carotid arteries. , 2005, Radiology.

[9]  P. Meyers,et al.  Treatment of mechanically-induced vasospasm of the carotid artery in a primate using intra-arterial verapamil: a technical case report , 2004, BMC cardiovascular disorders.

[10]  E. A. Stevens,et al.  Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent cerebral vasospasm. , 2004, Journal of Neurosurgery.

[11]  A. Takeshita,et al.  Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition , 2004, Hypertension.

[12]  F. Setacci,et al.  Protected Carotid Stenting: Clinical Advantages and Complications of Embolic Protection Devices in 442 Consecutive Patients , 2003, Stroke.

[13]  中島 正明.  Effects of Aging on Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits , 2001 .

[14]  I. Date,et al.  Effects of Aging on Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbits , 2001, Stroke.

[15]  J. Findlay.  Current Management of Aneurysmal Subarachnoid Hemorrhage Guidelines from the Canadian Neurosurgical Society , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  Findlay Jm.  Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. , 1997 .

[17]  R. Macdonald,et al.  Papaverine-sensitive vasospasm and arterial contractility and compliance after subarachnoid hemorrhage in dogs. , 1995, Neurosurgery.

[18]  T. Huber.  Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis , 2011 .

[19]  M. Shibuya,et al.  Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. , 2001, Acta neurochirurgica. Supplement.

[20]  W. Thies,et al.  Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. , 1994, Stroke.